The Next Frontier in Weight Loss: Why Doctors Are Urging Caution Over the Rise of Experimental Retatrutide
Main Facts: The Promise and Peril of the Triple-Agonist For millions of people navigating the complex landscape of chronic weight management, the advent of GLP-1 receptor agonists like Wegovy and…
